Capital International Inc’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Sell |
31,645
-39,802
| -56% | -$1.94M | 0.02% | 273 |
|
|
2025
Q1 | $2.43M | Sell |
71,447
-27,845
| -28% | -$948K | 0.03% | 254 |
|
|
2024
Q4 | $3.91M | Sell |
99,292
-3,284
| -3% | -$129K | 0.05% | 235 |
|
|
2024
Q3 | $4.82M | Buy |
102,576
+398
| +0.4% | +$18.7K | 0.06% | 209 |
|
|
2024
Q2 | $5.52M | Buy |
102,178
+10,517
| +11% | +$568K | 0.07% | 204 |
|
|
2024
Q1 | $6.25M | Buy |
91,661
+23,007
| +34% | +$1.57M | 0.08% | 195 |
|
|
2023
Q4 | $4.3M | Buy |
68,654
+341
| +0.5% | +$21.3K | 0.07% | 213 |
|
|
2023
Q3 | $3.1M | Buy |
68,313
+3,063
| +5% | +$139K | 0.06% | 209 |
|
|
2023
Q2 | $3.66M | Buy |
65,250
+4,195
| +7% | +$236K | 0.07% | 207 |
|
|
2023
Q1 | $2.76M | Buy |
61,055
+11,805
| +24% | +$534K | 0.06% | 200 |
|
|
2022
Q4 | $2M | Sell |
49,250
-3,939
| -7% | -$160K | 0.04% | 218 |
|
|
2022
Q3 | $3.48M | Buy |
53,189
+9,564
| +22% | +$625K | 0.08% | 185 |
|
|
2022
Q2 | $2.65M | Buy |
43,625
+7,444
| +21% | +$452K | 0.04% | 204 |
|
|
2022
Q1 | $2.27M | Sell |
36,181
-15,264
| -30% | -$958K | 0.03% | 229 |
|
|
2021
Q4 | $3.9M | Buy |
51,445
+2,287
| +5% | +$173K | 0.04% | 217 |
|
|
2021
Q3 | $5.5M | Sell |
49,158
-4,114
| -8% | -$460K | 0.05% | 195 |
|
|
2021
Q2 | $8.62M | Sell |
53,272
-17,463
| -25% | -$2.83M | 0.08% | 174 |
|
|
2021
Q1 | $8.62M | Sell |
70,735
-47,912
| -40% | -$5.84M | 0.08% | 170 |
|
|
2020
Q4 | $18.2M | Buy |
118,647
+6,867
| +6% | +$1.05M | 0.17% | 129 |
|
|
2020
Q3 | $9.35M | Buy |
+111,780
| New | +$9.35M | 0.1% | 147 |
|